Moscow finds it sad that Washington is calling for suspicion about the Russian Sputnik V vaccine. Russian Foreign Minister Sergei Lavrov said this. According to him, Russia “has never been friends with anyone” “against someone” and is developing cooperation based on mutual interests. At the same time, the Ministry of Health indicated a great interest in Sputnik V all over the world. Earlier, White House press secretary Jen Psaki said that Russia and China “are using their vaccines to achieve their own goals in the diplomatic arena.”
Russia regrets the attempts by the United States of America to ascribe a geopolitical plan to the spread of the Sputnik V coronavirus vaccine. This was stated by Russian Foreign Minister Sergei Lavrov during a press conference following talks with Togolese Foreign Minister Robert Dussey.
“Recently, representatives of the new US administration have called for suspicion of the Russian Sputnik V vaccine, since this, again, is“ the Kremlin’s geopolitical plan ”and“ one must be careful not to become dependent on the Russian Federation. ” What to say? If there is nothing to oppose to normal friendly communication between countries, if the only thing that can be said is this kind of statements, then this is sad, ”Lavrov said.
According to him, Moscow “never and with anyone” is not friends against anyone: “We always proceed from the fact that if Russia and its foreign partners have mutual attraction, then we have every right to develop our relations in such a way, how we will agree. “
Recall that on February 12, White House spokeswoman Jen Psaki said that Washington is observing attempts by Russia and China to use their success in developing vaccines against COVID-19 to achieve goals in the diplomatic arena.
- Sergey Lavrov found the US attempts to link the spread of Sputnik V with geopolitics to be sad
In turn, the Togolese minister said that the state is interested in purchasing the Sputnik V vaccine and is negotiating with the Russian Direct Investment Fund (RDIF). In addition, Togo will launch an administrative procedure for the certification of the drug developed by the specialists of the NFICEM named after honorary academician N.F. Gamalei.
“Our colleagues from Togo have already approached us with an official request for cooperation in the supply of this vaccine. It is necessary to take some actions, carry out procedures inside Togo, and as soon as this happens, we will be ready to consider already practical steps, ”the Russian Foreign Minister explained.
International recognition of “Sputnik V”
The Russian Ministry of Health is observing “great interest in the world” in the domestic vaccine. This was stated by the head of the department of state regulation of the circulation of medicines of the Ministry of Health Philip Romanov. According to him, the Russian side is discussing not only supplies, but also “a possible transfer of technologies” to scale up production.
“The effectiveness of its (vaccine. – RT) is high for today. Vaccination fears are, so to speak, in the past, ”he said during his speech at the conference on strategic cooperation“ New ways of development: Russian-German partnership ”.
At the same time, Romanov believes that interest in a drug developed to combat COVID-19 will have a positive effect on the inflow of investments into the Russian Federation.
“I think that digital indicators will appear a little later, but in terms of the spread of those innovations that were created by the Russian Federation, as you know, Russian vaccines have already been registered in 27 countries of the world, and this process is only at the beginning, so the investment forecast is only favorable. “, – explained Romanov.
On February 12, it became known that Sputnik V entered the top 3 vaccines against COVID-19 in terms of the number of approvals for use received worldwide. The Russian drug has passed the registration process under an accelerated procedure already in 27 countries of the world, the last of which are Montenegro, Kazakhstan, as well as Saint Vincent and the Grenadines (the first state of the Caribbean).
Sputnik V has received worldwide recognition as one of the key vaccines with which mankind will be able to protect itself from coronavirus infection and return to normal life, ”said Kirill Dmitriev, RDIF CEO.
On February 2, one of the most authoritative medical publications, The Lancet, published material confirming the high efficiency of Sputnik V. International experts have found that the domestic vaccine provides complete protection against severe forms of the disease, and its effectiveness is 91.6%.
Recall that on August 11, 2020, Russia was the first in the world to register a vaccine against coronavirus infection “Sputnik V”, which was developed by specialists of the NITsEM named after honorary academician N.F. Gamalei.
The drug is a two-component vector vaccine based on human adenovirus, which contains an insert in its genome that encodes a fragment of the SARS-CoV-2 S-protein and induces an immune response in the body. Vaccination of each person is carried out in two stages (again – 21 days after the first injection).
According to the Gamaleya Center, almost 7 million doses of the vaccine have already been released into civil circulation in Russia, while more than 1.7 million people received both components of the drug.
In addition, on February 10, the State Research Center of Virology and Biotechnology “Vector” sent the results of the first and second phases of clinical trials of another Russian vaccine against COVID-19 – “EpiVacCorona” to foreign scientific journals. Their publication is expected soon.